AbCellera Biologics Inc.
- ABCL
- NASDAQ
- Biotechnology
- AI-Driven Antibody Discovery
$11.80
Today −6.94%Quote Oct 16, 2026, 08:00 PM UTC
−7.31%over the last month
Max drawdown −20.4%From 1-month high −20.4%3 months +103.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$3.82B
Quote Oct 16
Next earnings
Nov 9
Expected, not confirmed
Analyst target
$15.40
+30.5% from here
Floor
$11.45
3.0% below price
Where the price sits
12 analysts
Analyst range, low to high
$7.00$30.00
- Price $11.80
- Resistance $11.81–$11.93
- Consensus $15.40
The price is right under resistance. Analysts' average target sits about 31% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ABCLPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $4.0M
- Research Fees$3.9M96.3%
- Licensing and Royalty Revenue$149,0003.7%
Industry
Biotechnology
Employees
562
Founded
2012